Dearborn Partners LLC Baxter International Inc Transaction History

Dearborn Partners LLC

$2.42 Billion
Q3 2024

A detailed history of Dearborn Partners LLC transactions in Baxter International Inc stock. As of the latest transaction made, Dearborn Partners LLC holds 7,258 shares of BAX stock, worth $241,038. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,258

Previous 7,258 -0.0%

Holding current value

$241,038

Previous $242,000 13.64%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$37.58 - $52.57 $6,012 - $8,411	-160 Reduced 2.16%	7,258 $294,000
Q4 2022 Feb 02, 2023	SELL	$49.7 - $57.71 $16,699 - $19,390	-336 Reduced 4.33%	7,418 $378,000
Q3 2022 Oct 25, 2022	BUY	$53.86 - $66.8 $2,100 - $2,605	39 Added 0.51%	7,754 $418,000
Q2 2022 Jul 20, 2022	SELL	$63.83 - $80.0 $20,744 - $26,000	-325 Reduced 4.04%	7,715 $496,000
Q1 2022 May 04, 2022	BUY	$76.85 - $89.45 $48,031 - $55,906	625 Added 8.43%	8,040 $623,000
Q4 2021 Jan 28, 2022	BUY	$74.57 - $87.19 $4,548 - $5,318	61 Added 0.83%	7,415 $637,000
Q2 2021 Jul 26, 2021	BUY	$80.5 - $88.01 $7,728 - $8,448	96 Added 1.32%	7,354 $592,000
Q1 2021 Apr 29, 2021	SELL	$76.38 - $86.03 $41,321 - $46,542	-541 Reduced 6.94%	7,258 $612,000
Q1 2019 May 01, 2019	SELL	$64.48 - $81.31 $19,344 - $24,393	-300 Reduced 3.7%	7,799 $634,000
Q4 2018 Feb 04, 2019	BUY	$61.45 - $77.8 $102,129 - $129,303	1,662 Added 25.82%	8,099 $533,000
Q3 2018 Oct 24, 2018	BUY	$70.71 - $77.75 $7,070 - $7,775	100 Added 1.58%	6,437 $496,000
Q1 2018 May 01, 2018	SELL	$62.56 - $72.26 $12,949 - $14,957	-207 Reduced 3.16%	6,337 $412,000
Q2 2017 Aug 09, 2017	BUY	N/A	6,544	6,544 $396,000

Others Institutions Holding BAX

# of Institutions

1,006

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Account

Dearborn Partners LLC Baxter International Inc Transaction History